Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
The Prostate
|
January 3, 2013
Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart
Jennifer Ko, Sara M Falzarano, Esteban Walker, et al.
Pigment Cell & Melanoma Research
|
March 5, 2025
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants
Isabella Ribaudo, Michelle Arbesman, Ying Ni, et al.
Melanoma Research
|
May 15, 2020
Utilization and impact of immunotherapy in stage IV melanoma using the National Cancer Database
Rosalynn R Z Conic, Rebecca Knackstedt, Tamara A Sussman, et al.
Neuro-Oncology
|
June 4, 2011
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2018
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
Lillian Sun, Pauline Funchain, Jung Min Song, et al.
The Journal of Applied Laboratory Medicine
|
April 7, 2021
Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories
Alexis Plaga, Ruhan Wei, Elizabeth Olson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2009
Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction
Soumika Biswas, Kaushik Biswas, Amy Richmond, et al.
Melanoma Research
|
January 29, 2026
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials
Daniela Duarte-Bateman, Joseph M Escandón, Alan Shen, et al.
Cancer Immunology, Immunotherapy : CII
|
December 16, 2018
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γ
Lin Lin, Patricia Rayman, Paul G Pavicic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma
Alan Shen, Michelle Arbesman, Roshan Lodha, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
The Prostate
|
January 3, 2013
Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart
Jennifer Ko, Sara M Falzarano, Esteban Walker, et al.
Pigment Cell & Melanoma Research
|
March 5, 2025
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants
Isabella Ribaudo, Michelle Arbesman, Ying Ni, et al.
Melanoma Research
|
May 15, 2020
Utilization and impact of immunotherapy in stage IV melanoma using the National Cancer Database
Rosalynn R Z Conic, Rebecca Knackstedt, Tamara A Sussman, et al.
Neuro-Oncology
|
June 4, 2011
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, et al.
Journal for Immunotherapy of Cancer
|
May 17, 2018
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
Lillian Sun, Pauline Funchain, Jung Min Song, et al.
The Journal of Applied Laboratory Medicine
|
April 7, 2021
Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories
Alexis Plaga, Ruhan Wei, Elizabeth Olson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2009
Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction
Soumika Biswas, Kaushik Biswas, Amy Richmond, et al.
Melanoma Research
|
January 29, 2026
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials
Daniela Duarte-Bateman, Joseph M Escandón, Alan Shen, et al.
Cancer Immunology, Immunotherapy : CII
|
December 16, 2018
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γ
Lin Lin, Patricia Rayman, Paul G Pavicic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma
Alan Shen, Michelle Arbesman, Roshan Lodha, et al.
Page
of 6